This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Good Works II Acquisition Corp.(NasdaqCM:GWII) dropped from NASDAQ Composite Index CI
Direct Biologics LLC cancelled the acquisition of Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others in a reverse merger transaction. CI
Good Works II Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Good Works II Acquisition, Direct Biologics Enter SPAC Merger Deal MT
Direct Biologics to list in U.S. via $1 billion SPAC RE
Good Works II Acquisition Signs Letter of Intent for Business Combination With Direct Biologics MT
Direct Biologics LLC announced that it expects to receive $100 million in funding from IB Investments 1 LLC, and other investors CI
Direct Biologics LLC entered into a non-binding letter of intent to acquire Good Works II Acquisition Corp. from I-B Good Works 2, LLC and others for approximately $630 million in a reverse merger transaction. CI
Good Works II Acquisition Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Good Works II Acquisition Corp. Announces Executive Changes CI
Good Works Ii Acquisition Corp. Announces Executive Changes CI
Good Works II Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Good Works II Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Good Works II Acquisition Corp.(NasdaqCM:GWII) added to NASDAQ Composite Index CI
Good Works II Acquisition Corp. has completed an IPO in the amount of $200 million. CI
Good Works II Acquisition Corp. has filed an IPO in the amount of $200 million. CI
Chart Good Works II Acquisition Corp.
More charts
Good Works II Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Company intends to focus on pursuing an acquisition of or merger with high-growth companies that need significant capital because of disruptions related to COVID-19 and the resulting structural changes occurring in some industries as a result, or other high-growth businesses in financial distress due temporary disruptions in their business that occurred due to COVID-19. The Company has no operations. The Company has no revenues.
More about the company
  1. Stock Market
  2. Equities
  3. GWII Stock
  4. News Good Works II Acquisition Corp.
  5. Good Works II Acquisition, Direct Biologics Enter SPAC Merger Deal